Marine Drugs | Free Full-Text | Saringosterol f...
Frontiers | Nano-drug delivery systems (NDDS) i...
Pathophysiology of non-alcoholic fatty liver di...
Applications of the Cholesterol Metabolite, 4β-...
Identification and evaluation of a lipid-loweri...
Schematic description of the main routes of ste...
Schematic diagram representing the roles of die...
Antioxidant Activity of γ-Oryzanol: A Complex N...
Physiological Suppression of Lipotoxic Liver Da...
Full article: Thyroid hormone induction of mito...
Acetyl CoA Carboxylase Inhibition Reduces Hepat...
Figure 1 from Gut microbiota and non-alcoholic ...
Marine Drugs | Free Full-Text | Fucoidan and Fu...
Madrigal Pharmaceuticals Setting The Standard (...
Proposed mechanism of action of treatments for ...
AMPK/mTOR pathway significance in healthy liver...
Figure 4 from The metabolic adaptation of bile ...
P(URI)fying Novel Drivers of NASH and HCC: A Fe...
DHA-Enriched Phosphatidylserine Combats NAFLD &...
Proposed mechanisms of action of CM414 involved...
Metabolic alterations resulting in hepatic trig...
Frontiers | miRNA Dysregulation in the Developm...
(PDF) Cholesterol and Inflammation at the Cross...
New cardiovascular prevention guidelines: How t...
(PDF) Thyroid hormone action in metabolic regul...
IJMS | Free Full-Text | MyD88 in Macrophages En...
The mechanisms of major metabolic targets regul...
ATP-citrate lyase (ACLY) is an enzyme possessin...
Antioxidants | Free Full-Text | N-Acetyl Cystei...
Bempedoic Acid, the First-in-Class Oral ATP Cit...
Lipid metabolism. The mobilization of fatty aci...
G protein-coupled receptor 35 attenuates nonalc...
The Effect of Coenzyme Q10 Supplementation on B...
Benefits of lifestyle modification in NAFLD | Gut
Upregulated CYP 2E1 promotes the development of...